AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Emtricitabine; Tenofovir Disoproxil Fumarate in Nigeria
5 products registered with NAFDAC — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Truvada Tablets (check pack size) Tablet | 04-8774 | Phillips Pharmaceuticals (Nigeria) Limited | active | 24 May 2028 |
| Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 and 300 mg Tablet | A4-100333 | Onifam Laboratories Limited | active | 22 Feb 2028 |
| Emtricitabine & Tenofovir Disoproxil Fumarate Tablets 200/300 Tablet | A4-100081 | Ranbaxy Nigeria Limited | active | 25 Aug 2026 |
| Jyna Emtricitabine and Tenofovir Disoproxil Fumarate Tablet | C4-0479 | Jyna Pharma Ltd | active | 6 May 2026 |
| Emtricitabine 200 mg/Tenofovir Disoproxil Fumarate 300 mg Tablets** Tablet | A4-2126 | Healthline Limited | active | 24 Feb 2026 |
Emtricitabine; Tenofovir Disoproxil Fumarate — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Emtricitabine; Tenofovir Disoproxil Fumarate, of which 5 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Emtricitabine; Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.